Pelvic Congestion Syndrome and Endometriosis (VES)

June 11, 2019 updated by: Mohamed Mabrouk, IRCCS Azienda Ospedaliero-Universitaria di Bologna

Ultrasound Evaluation of the Prevalence of Pelvic Congestion Syndrome in Patients With Endometriosis

The pelvic congestion syndrome (PCS) is a complex and multifactorial condition associated with inflammatory and hormonal etiophatogenesis similar to the endometriosis.

Furthermore, both pathologies share same clinical symptoms as chronic pelvic pain and dyspareunia.

Our hypothesis is that PCS prevalence is higher in patients with endometriosis than in those without clinical or ultrasound signs of endometriosis.

Study Overview

Detailed Description

Patients undergoing routine gynecological examinations are included in the study.

Patients are divided into 2 groups:

  • Group A: with endometriosis
  • Group B: without clinical or ultrasound signs of endometriosis This is an observational, monocentric, prospective, exploratory study. The aim is to assess PCS incidence, associated symptoms and ultrasound characteristics in patients with endometriosis and to compare those findings to those of patients who do not present clinical or ultrasound signs of endometriosis.

The study also evaluates the correlation between:

  • Type of pain symptoms (dysmenorrhea, chronic pelvic pain, ovulation pain, dyspareunia, dysuria, dyschezia) and PCS
  • Pain severity (assessed according to VAS scale from 0= no pain to 10= unbearable pain) and PCS
  • Symptoms and ongoing medical treatments
  • History of pelvic surgery and PCS.

Ultrasound parameters of pelvic vascular insufficiency are:

  • Ovarian vein diameter <4mm
  • Slow ovarian blood flow (<3cm/sec)
  • Retrograde blood flow
  • Dilated arcuate veins communicating with pelvic varices
  • The presence of pelvic varices is evaluated qualitatively as normal, moderate and serious

This evaluation includes the study of uterine and ovarian vessels, using different techniques:

  • Standard 2D study: it allows to measure vessels diameter
  • Vascular doppler study: it allows to evaluate flow direction and blood speed
  • 3D color study: it allows a three- dimensional reconstruction of vessels and a more accurate qualitative assessment of the congestion degree.
  • Ultrasound images are evaluated independently by two operators.

Study Type

Observational

Enrollment (Anticipated)

160

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • BO
      • Bologna, BO, Italy, 40138
        • Recruiting
        • Gynecology and Physiopathology of Human Reproductive Unit, University of Bologna, S. Orsola-Malpighi Hospital
        • Contact:
        • Principal Investigator:
          • Mohamed Mabrouk
        • Principal Investigator:
          • Renato Seracchioli
        • Principal Investigator:
          • Diego Raimondo
        • Sub-Investigator:
          • Simona Del Forno
        • Sub-Investigator:
          • Raffaella Iodice
        • Sub-Investigator:
          • Manuela Mastronardi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Patients undergoing routine gynecological examinations in our center are included in the study.

Description

Inclusion Criteria (Group A):

  • Obtaining Informed Consent
  • Nulliparity
  • Clinical or ultrasounds signs of endometriosis

Inclusion Criteria (Group B):

  • Obtaining Informed Consent
  • Nulliparity

Exclusion Criteria:

  • Menopause
  • Actual or previous pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group A: endometriosis
assessment of pain symptoms at first medical examination; assessment of pelvic vascular insufficiency signs.
First medical examination consists of collection of medical history and standard gynecological examination (bimanual gynecological examination and abdominopelvic ultrasounds). Data regarding age, Body Mass Index, ongoing hormone therapy and pelvic pain symptoms, assessed according to Visual Analogue Scale (VAS) (from 0= no pain to 10= unbearable pain), are collected. The presence of perineal or lower limb varices and the presence and localization of evoked pain at bimanual gynecological examination are also evaluated.

Assessment of pelvic vascular insufficiency in conducted using abdominopelvic ultrasounds, according to the following parameters:

  • Ovarian vein diameter <4mm
  • Slow ovarian blood flow (<3cm/sec)
  • Retrograde blood flow
  • Dilated arcuate veins communicating with pelvic varices The presence of pelvic varices is evaluated qualitatively as normal, moderate and serious

This evaluation includes the study of uterine and ovarian vessels, using different techniques:

  • Standard 2D study, to measure vessels diameter
  • Vascular doppler study, to evaluate flow direction and blood speed
  • 3D color study, for a three- dimensional reconstruction of vessels and a more accurate qualitative assessment of the congestion degree.
Group B: no endometriosis
assessment of pain symptoms at first medical examination; assessment of pelvic vascular insufficiency signs.
First medical examination consists of collection of medical history and standard gynecological examination (bimanual gynecological examination and abdominopelvic ultrasounds). Data regarding age, Body Mass Index, ongoing hormone therapy and pelvic pain symptoms, assessed according to Visual Analogue Scale (VAS) (from 0= no pain to 10= unbearable pain), are collected. The presence of perineal or lower limb varices and the presence and localization of evoked pain at bimanual gynecological examination are also evaluated.

Assessment of pelvic vascular insufficiency in conducted using abdominopelvic ultrasounds, according to the following parameters:

  • Ovarian vein diameter <4mm
  • Slow ovarian blood flow (<3cm/sec)
  • Retrograde blood flow
  • Dilated arcuate veins communicating with pelvic varices The presence of pelvic varices is evaluated qualitatively as normal, moderate and serious

This evaluation includes the study of uterine and ovarian vessels, using different techniques:

  • Standard 2D study, to measure vessels diameter
  • Vascular doppler study, to evaluate flow direction and blood speed
  • 3D color study, for a three- dimensional reconstruction of vessels and a more accurate qualitative assessment of the congestion degree.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of pelvic congestive syndrome in patients with endometriosis
Time Frame: 1 day, first medical examination
Comparison of pelvic congestive syndrome symptoms and ultrasounds characteristics, assessed by standard gynecological examination (bimanual gynecological examination and gynecological ultrasounds), between patients with endometriosis (Group A) and without clinical or ultrasound signs of endometriosis.
1 day, first medical examination

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation between type of pain and pelvic congestive syndrome
Time Frame: 1 day, first medical examination
Evaluation of the type of pain (dysmenorrhea, chronic pelvic pain, ovulation pain, dyspareunia, dysuria, dyschezia) presented by patients with pelvic congestive syndrome.
1 day, first medical examination
Correlation between pain severity and pelvic congestive syndrome
Time Frame: 1 day, first medical examination
Evaluation of a possible correlation between pain severity and the presence of pelvic congestive syndrome. Pain severity is assessed according to Visual Analogue Scale (VAS scale from 0= no pain to 10= unbearable pain).
1 day, first medical examination
Correlation between symptoms and ongoing medical treatments
Time Frame: 1 day, first medical examination
Evaluation of a possible correlation between symptoms and ongoing medical treatments in patients with pelvic congestive syndrome
1 day, first medical examination
Correlation between history of pelvic surgery and pelvic congestive syndrome
Time Frame: 1 day, first medical examination
Evaluation of a possible correlation between history of pelvic surgery and the presence of pelvic congestive syndrome
1 day, first medical examination

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 14, 2018

Primary Completion (Anticipated)

July 1, 2019

Study Completion (Anticipated)

August 1, 2019

Study Registration Dates

First Submitted

June 11, 2018

First Submitted That Met QC Criteria

June 22, 2018

First Posted (Actual)

June 26, 2018

Study Record Updates

Last Update Posted (Actual)

June 12, 2019

Last Update Submitted That Met QC Criteria

June 11, 2019

Last Verified

June 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • VES Study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endometriosis

Clinical Trials on assessment of pain symptoms at first medical examination

3
Subscribe